Gotimmune Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Gotimmune General Information


Operator of a biopharmaceutical company intended for the development of therapeutic products. The company develops a portfolio of products with high medical value that ultimately, through global partnerships, will result in successful cures, enabling patients to avail themselves of the treatment of incurable diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Therapeutic Devices
Drug Discovery
Primary Office
  • Erik Dahlbergsgatan 11A
  • floor 2
  • 411 26 Gothenburg
  • Sweden
+46 070-713 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gotimmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jan-2023 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Gotimmune’s complete valuation and funding history, request access »

Gotimmune Executive Team (2)

Name Title Board Seat Contact Info
Jan Holmgren Co-Founder
Nils Lycke Ph.D Co-Founder
To view Gotimmune’s complete executive team members history, request access »

Gotimmune Board Members (1)

Name Representing Role Since
Klementina Österberg GU Ventures Chairman 000 0000
To view Gotimmune’s complete board members history, request access »